For help on how to get the results you want, see our search tips.
8666 results
Keyword Remove keyword
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Adynovi
rurioctocog alfa pegol, Hemophilia A
Date of authorisation: 08/01/2018,
, Revision: 3, Authorised, Last updated: 23/08/2019
-
List item
Human medicine European public assessment report (EPAR): Aerinaze
desloratadine, pseudophedrine sulfate, Rhinitis, Allergic, Seasonal
Date of authorisation: 30/07/2007, Revision: 18, Authorised, Last updated: 28/01/2021 -
List item
Human medicine European public assessment report (EPAR): Aerius
desloratadine, Rhinitis, Allergic, Perennial, Urticaria, Rhinitis, Allergic, Seasonal
Date of authorisation: 15/01/2001, Revision: 42, Authorised, Last updated: 06/03/2020 -
List item
Human medicine European public assessment report (EPAR): Aerivio Spiromax
salmeterol xinafoate, fluticasone propionate, Pulmonary Disease, Chronic Obstructive, Asthma
Date of authorisation: 18/08/2016, Revision: 2, Withdrawn, Last updated: 15/01/2020 -
List item
Human medicine European public assessment report (EPAR): Afinitor
everolimus, Carcinoma, Renal Cell, Breast Neoplasms, Pancreatic Neoplasms
Date of authorisation: 02/08/2009, Revision: 25, Authorised, Last updated: 06/07/2020 -
List item
Human medicine European public assessment report (EPAR): Aflunov
influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: A/turkey/Turkey/1/05 (H5N1)-like strain (NIBRG-23), Influenza, Human, Immunization, Disease Outbreaks
Date of authorisation: 28/11/2010, Revision: 12, Authorised, Last updated: 11/11/2019 -
List item
Human medicine European public assessment report (EPAR): Afstyla
lonoctocog alfa, Hemophilia A
Date of authorisation: 04/01/2017,, Revision: 7, Authorised, Last updated: 26/08/2020
-
List item
Human medicine European public assessment report (EPAR): Agenerase
amprenavir, HIV Infections
Date of authorisation: 20/10/2000, Revision: 18, Withdrawn, Last updated: 21/06/2011 -
List item
Human medicine European public assessment report (EPAR): Aimovig
erenumab, Migraine Disorders
Date of authorisation: 26/07/2018,, Revision: 5, Authorised, Last updated: 09/09/2020
-
List item
Human medicine European public assessment report (EPAR): Airexar Spiromax
salmeterol, fluticasone propionate, Pulmonary Disease, Chronic Obstructive, Asthma
Date of authorisation: 18/08/2016, Revision: 2, Withdrawn, Last updated: 02/07/2019 -
List item
Human medicine European public assessment report (EPAR): Ajovy
fremanezumab, Migraine Disorders
Date of authorisation: 28/03/2019,, Revision: 4, Authorised, Last updated: 04/11/2020
-
List item
Human medicine European public assessment report (EPAR): Akynzeo
netupitant, palonosetron hydrochloride, Vomiting, Cancer, Nausea
Date of authorisation: 27/05/2015, Revision: 8, Authorised, Last updated: 29/06/2020 -
List item
Human medicine European public assessment report (EPAR): Aldara
imiquimod, Condylomata Acuminata, Keratosis, Keratosis, Actinic, Carcinoma, Basal Cell
Date of authorisation: 18/09/1998, Revision: 27, Authorised, Last updated: 15/12/2020 -
List item
Human medicine European public assessment report (EPAR): Aldurazyme
laronidase, Mucopolysaccharidosis I
Date of authorisation: 09/06/2003, Revision: 20, Authorised, Last updated: 09/12/2020 -
List item
Human medicine European public assessment report (EPAR): Alecensa
alectinib hydrochloride, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 16/02/2017,, Revision: 8, Authorised, Last updated: 19/06/2020
-
List item
Human medicine European public assessment report (EPAR): Alimta
pemetrexed, Mesothelioma, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 20/09/2004, Revision: 25, Authorised, Last updated: 27/10/2020 -
List item
Human medicine European public assessment report (EPAR): Alisade
fluticasone furoate, Rhinitis, Allergic, Perennial, Rhinitis, Allergic, Seasonal
Date of authorisation: 06/10/2008, Revision: 4, Withdrawn, Last updated: 18/10/2011 -
List item
Human medicine European public assessment report (EPAR): Alkindi
hydrocortisone, Adrenal Insufficiency
Date of authorisation: 09/02/2018, Revision: 5, Authorised, Last updated: 18/11/2019 -
List item
Human medicine European public assessment report (EPAR): Allex
desloratadine, Rhinitis, Allergic, Perennial, Urticaria, Rhinitis, Allergic, Seasonal
Date of authorisation: 15/01/2001, Withdrawn, Last updated: 31/12/2009 -
List item
Human medicine European public assessment report (EPAR): Alli (previously Orlistat GSK)
orlistat, Obesity
Date of authorisation: 22/07/2007, Revision: 17, Authorised, Last updated: 24/08/2020 -
List item
Human medicine European public assessment report (EPAR): Alofisel
darvadstrocel, Rectal Fistula
Date of authorisation: 23/03/2018,, 
, Revision: 6, Authorised, Last updated: 04/01/2021
-
List item
Human medicine European public assessment report (EPAR): Aloxi
palonosetron hydrochloride, Vomiting, Cancer
Date of authorisation: 22/03/2005, Revision: 21, Authorised, Last updated: 19/07/2018 -
List item
Human medicine European public assessment report (EPAR): Alpheon
recombinant human interferon alfa-2a, Hepatitis C, Chronic
Date of refusal: 05/09/2006,
, Refused, Last updated: 28/06/2006
-
List item
Human medicine European public assessment report (EPAR): Alpivab
Peramivir, Influenza, Human
Date of authorisation: 13/04/2018,, Revision: 2, Withdrawn, Last updated: 09/12/2020
-
List item
Human medicine European public assessment report (EPAR): Alprolix
eftrenonacog alfa, Hemophilia B
Date of authorisation: 12/05/2016,, , Revision: 5, Authorised, Last updated: 04/11/2020